A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
A Canadian study to evaluate early use of adalimumab after methotrexate failure in early
rheumatoid arthritis. The study hypothesis will verify if adalimumab effectively reduces
joint damage in more participants when introduced earlier than in current practice.